Abortion, Induced Clinical Trial
Official title:
Developing and Testing Interventions to Address Use of Conscientious Objection to Deny Women's Access to Abortion Care in Mexico and South Africa
Verified date | July 2020 |
Source | Ipas |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary purpose of this research is to develop strategies and interventions to mitigate the impact of conscientious objection on women's access to safe abortion care in Mexico and South Africa using a user-centered design approach and test the feasibility and effectiveness of these interventions.
Status | Terminated |
Enrollment | 317 |
Est. completion date | June 30, 2020 |
Est. primary completion date | March 17, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
South Africa Inclusion Criteria: - All staff currently working in selected health facilities - Able to provide informed consent Exclusion Criteria: - Unable to provide informed consent Mexico Inclusion Criteria: - Doctors/anyone eligible to be an abortion provider working in selected health facilities - Able to provide informed consent Exclusion Criteria: - Unable to provide informed consent |
Country | Name | City | State |
---|---|---|---|
Mexico | Ipas Central America and Mexico | Mexico City | |
South Africa | Ipas South Africa | Johannesburg |
Lead Sponsor | Collaborator |
---|---|
Ipas |
Mexico, South Africa,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Behavior making it easier for women to access abortion care | Proportion of health facility staff exhibiting at least one behavior to make it easier for women to access abortion care (e.g. helped a woman find the abortion care unit, provided positive support to a woman seeking abortion care, gave accurate information to a woman seeking abortion care, etc.). | Past 30 days | |
Primary | Behavior making it more difficult for women to access abortion care | Proportion of health facility staff exhibiting at least one behavior to make it more difficult for women to access abortion care (e.g. gave incorrect directions to a woman seeking abortion care, told a woman abortion services were not available at the facility, tried to convince a woman that she should not have an abortion, etc.). | Past 30 days | |
Primary | Intention to provide abortion service, referral, or information | Proportion of health facility staff reporting they would provide abortion service, referral or information to women seeking abortion care in their health unit in the next few days if needed. | Next few days | |
Secondary | Interest in attending an abortion care training | Proportion of providers (doctors, nurses, or midwives) reporting being interested in attending an abortion care training. | Assessed at baseline and at 30-day follow-up | |
Secondary | Stigmatizing Attitudes Beliefs and Actions Scale (SABAS) score | Average Stigmatizing Attitudes Beliefs and Actions Scale (SABAS) score. The SABAS is a tool designed to measure abortion stigma at the individual and community level, ranging from a minimum of 18 to a maximum of 90. A higher score represents more stigmatizing attitudes and beliefs about women who have an abortion (worse outcome). | Assessed at baseline and at 30-day follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01541293 -
Intrauterine Lidocaine for Laminaria
|
Phase 1 | |
Completed |
NCT00177333 -
Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens
|
Phase 4 | |
Completed |
NCT00370487 -
Comparison of the Safety of First Trimester Abortions Performed by Physicians and Non-Physicians in South Africa and Viet Nam.
|
N/A | |
Completed |
NCT00188071 -
Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen
|
N/A | |
Completed |
NCT02277249 -
Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
|
N/A | |
Completed |
NCT00386867 -
A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP
|
N/A | |
Completed |
NCT00677755 -
Medical Abortion for Emergency Contraception Failure
|
N/A | |
Completed |
NCT02279914 -
Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial
|
N/A | |
Completed |
NCT01615731 -
Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks
|
N/A | |
Completed |
NCT01597726 -
Cervical Priming Before Dilation & Evacuation
|
N/A | |
Completed |
NCT02318212 -
Dilapan-S / Dilasoft E-Registry in Induced Abortion
|
N/A | |
Terminated |
NCT00855842 -
Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion
|
N/A | |
Completed |
NCT00330993 -
Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation
|
Phase 2 | |
Completed |
NCT00382538 -
Mifepristone and Mid-Trimester Termination of Pregnancy
|
N/A | |
Completed |
NCT03080493 -
Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial
|
Phase 4 | |
Completed |
NCT02485444 -
Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion
|
Phase 4 | |
Completed |
NCT00969982 -
Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))
|
N/A | |
Recruiting |
NCT02480543 -
Different Routes of Misoprostol Prior to First Trimester Surgical Abortion
|
Phase 4 | |
Completed |
NCT00870272 -
Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)
|
N/A | |
Completed |
NCT02048098 -
Misoprostol for Second Trimester Termination of Pregnancy
|
Phase 3 |